Business
TempraMed Expands U.S. Manufacturing Capacity with New Production Facility in Florida
New facility increases output, reduces cost of goods sold (COGS) and enhances service for B2B customers to address the forecasted increased demand for productsHighlights: Manufacturing site in Florida expands TempraMed's U.S. production footprintIncreases capacity to meet rising demand from healthcare organizations, pharmacies, payors, and device manufacturersShortens delivery timelines and improves service for customers in the United States where majority of devices have been sold to...
About this update from Tempramed Technologies Ltd.
[{"type":"text","content":"New facility increases output, reduces cost of goods sold (COGS) and enhances service for B2B customers to address the forecasted increased demand for products","length":159,"tagName":"p","attribs":{"class":"nfSubHeading"},"className":""},{"type":"text","content":"Highlights: ","length":11,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Manufacturing site in Florida expands TempraMed's U.S. production footprint","length":79,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Increases capacity to meet rising demand from healthcare organizations, pharmacies, payors, and device manufacturers","length":116,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Shortens delivery timelines and improves service for customers in the United States where majority of devices have been sold to date","length":132,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Reduces COGS through localized production, improved logistics efficiency, and advanced manufacturing processes","length":110,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Opens new global markets for B2B customers, and large, global retailers ","length":71,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Reinforces TempraMed's long-term commercialization strategy and supply-chain resilience","length":91,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":599,"olType":false},{"type":"text","content":"Vancouver, British Columbia--(Newsfile Corp. - December 17, 2025) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to announce that it has opened an additional U.S. manufacturing facility in Florida. The additional site expands the Company's operational capacity and enhances its ability to serve the rapidly growing demand for TempraMed's temperature-stable medication-storage devices across the United States and globally.","length":605,"tagName":"p"},{"type":"text","content":"Due to anticipated B2B demand, the new facility will support high-volume production of TempraMed's core product line-including VIVI Cap™, VIVI Epi™, as well as the upcoming products, including VIVI Box™ smart-stor...